Determination of Glomerular Filtration Rate After Contrast-Enhanced CT Among Critically Ill Patients: Support for a New Procedure
Authors:
- Bertil KågedalBKBertil Kågedal
- Anders HelldénAHAnders Helldén
- Dženeta Nezirević DernrothDDDženeta Nezirević Dernroth
- Anders Lindgaard AndersenAAAnders Lindgaard Andersen
- Andreas MD EkmanAEAndreas MD Ekman
- Mats HaglundMHMats Haglund
- Bharti KatariaBKBharti Kataria
- Frida OskarssonFOFrida Oskarsson
- Lovisa TobiesonLTLovisa Tobieson
- Åse ÖstholmÅÖÅse Östholm
- Håkan HanbergerHHHåkan Hanberger
Open Access
- 14 May 2025
- journal article
- research article
- Published by Wolters Kluwer Health in Critical Care Explorations
- Vol. 7 (5) , e1269
Abstract
OBJECTIVES: To measure glomerular filtration rate using iohexol plasma clearance (mGFRiohexol) in critically ill patients using the high doses of iohexol administered at CT and to evaluate its agreements with urinary creatinine clearance (uClcr) and estimated glomerular filtration rates (eGFRs), calculated from plasma concentrations of creatinine (eGFRcr) and cystatin C (eGFRcys). DESIGN: Prospective observational cohort study. SETTING: ICUs across Southeast Sweden. PATIENTS: Critically ill adult patients. INTERVENTIONS AND MEASUREMENTS: Twenty-six ICU patients were given high doses of iohexol (range, 27–140 mL) for contrast-enhanced CT, whereafter blood samples were taken in the elimination phase for determination of mGFRiohexol. Plasma iohexol concentrations were determined by high-performance liquid chromatography and mGFRiohexol was calculated. Standard dose (5 mL) of iohexol was administered the following days to compare low-dose clearance results with the high-dose clearance results. Six-hour uClcr was performed four times a day and averaged. MAIN RESULTS: Mean ± sd mGFRiohexol after CT was 77.4 ± 38.1 mL/min (n = 26), and uClcr was 97.3 ± 58.2 mL/min (n = 25) in the critically ill patients. There was a strong positive correlation between mGFRiohexol determined with high and low doses of iohexol in patients with normal or high mGFRiohexol (coefficient of determination [R 2] = 0.88; p < 0.001) and between mGFRiohexol and uClcr (R 2 = 0.87; p < 0.001). eGFRcr overestimated mGFRiohexol and eGFRcys underestimated mGFRiohexol. CONCLUSIONS: mGFRiohexol after contrast-enhanced CT compares well with mGFRiohexol after standard low-dose iohexol respectively uClcr. Over- and underestimation of mGFRiohexol by eGFRcr and eGFRcys is probably explained by increased tubular secretion of creatinine and increased production of cystatin C in intensive care patients.Keywords
This publication has 29 references indexed in Scilit:
- A physiological model for iohexol plasma clearance supporting diagnostics of kidney functionClinica Chimica Acta, 2024
- Assessing bias in GFR estimating equations: improper GFR stratification can yield misleading resultsPediatric Nephrology, 2024
- Comparative study of plasma clearance of iohexol at different injection dosesClinica Chimica Acta, 2022
- Verification of separate measurement procedures where analytical determinations influence the clinical interpretation of GFR: Iohexol quantitation by HPLC and LC-MS/MSClinical Biochemistry, 2019
- Determination of iohexol in human serum by a semi-automated liquid chromatography tandem mass spectrometry methodClinical Biochemistry, 2015
- Kidney Transplant Donor Glomerular Filtration Rate by Iohexol Clearance During Computerized Tomographic Angiography of the KidneysTransplantation Proceedings, 2013
- Performance of iohexol determination in serum and urine by HPLC: Validation, risk and uncertainty assessmentClinica Chimica Acta, 2008
- Determination of iohexol clearance by high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS)Journal of Chromatography B, 2006
- Development and validation of an HPLC-UV method for determination of iohexol in human plasmaJournal of Chromatography B, 2005
- Contrast Media and Glomerular Filtration: Dose Dependence of Clearance for Three AgentsJournal of Pharmaceutical Sciences, 1988